CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise 10b5-1 | +8 | $43.63 | $349 | 16,194 |
| 2026-11-11 | Mara Joseph Anthony Jr Chief Financial Officer | Sale 10b5-1 | −8 | $59.75 | $478 | 16,186 |
| 2026-11-11 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +8 | 134,992 | ||
| 2026-11-10 | MCLAUGHLIN KEVIN F Director | Option exercise 10b5-1 | +7,000 | $13.05 | $91K | 25,300 |
| 2026-11-10 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −7,000 | $58.96 | $413K | 18,300 |
| 2026-11-10 | MCLAUGHLIN KEVIN F Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | +7,000 | 0 | ||
| 2026-11-09 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise 10b5-1 | +25,000 | $43.63 | $1.1M | 41,186 |
| 2026-11-09 | Mara Joseph Anthony Jr Chief Financial Officer | Sale 10b5-1 | −25,000 | $58.26 | $1.5M | 16,186 |
| 2026-11-09 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +25,000 | 135,000 | ||
| 2026-11-09 | ZERBE ROBERT L MD Director | Option exercise 10b5-1 | +2,000 | $13.05 | $26K | 34,995 |
| 2026-11-09 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −2,000 | $57.88 | $116K | 32,995 |
| 2026-11-09 | ZERBE ROBERT L MD Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | +2,000 | 0 | ||
| 2026-11-06 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise 10b5-1 | +14,068 | $34.90 | $491K | 30,254 |
| 2026-11-06 | Mara Joseph Anthony Jr Chief Financial Officer | Sale 10b5-1 | −14,068 | $53.41 | $751K | 16,186 |
| 2026-11-06 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise 10b5-1 | +14,573 | $29.82 | $435K | 30,759 |
| 2026-11-06 | Mara Joseph Anthony Jr Chief Financial Officer | Sale 10b5-1 | −14,573 | $53.43 | $779K | 16,186 |
| 2026-11-06 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +14,068 | 39,269 | ||
| 2026-11-06 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +14,573 | 21,250 | ||
| 2026-11-05 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise 10b5-1 | +10,932 | $34.90 | $382K | 27,118 |
| 2026-11-05 | Mara Joseph Anthony Jr Chief Financial Officer | Sale 10b5-1 | −10,932 | $53.40 | $584K | 16,186 |
Page 1 of 75 · 1,497 trades